Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Current Leases (2019 - 2025)

Cardiff Oncology (CRDF) has disclosed Current Leases for 7 consecutive years, with $730000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases rose 2.82% to $730000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $730000.0 through Dec 2025, up 2.82% year-over-year, with the annual reading at $730000.0 for FY2025, 2.82% up from the prior year.
  • Current Leases hit $730000.0 in Q4 2025 for Cardiff Oncology, up from $726000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $730000.0 in Q4 2025 to a low of $402000.0 in Q2 2021.
  • Historically, Current Leases has averaged $665750.0 across 5 years, with a median of $685500.0 in 2023.
  • Biggest five-year swings in Current Leases: crashed 54.19% in 2021 and later skyrocketed 66.67% in 2022.
  • Year by year, Current Leases stood at $551000.0 in 2021, then grew by 22.5% to $675000.0 in 2022, then increased by 2.37% to $691000.0 in 2023, then grew by 2.75% to $710000.0 in 2024, then grew by 2.82% to $730000.0 in 2025.
  • Business Quant data shows Current Leases for CRDF at $730000.0 in Q4 2025, $726000.0 in Q3 2025, and $721000.0 in Q2 2025.